Pfizer Limited
Pfizer Limited (PFIZER.BO) Stock Overview
Explore Pfizer Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
235.3B
P/E Ratio
27.58
EPS (TTM)
$183.33
ROE
0.21%
PFIZER.BO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Pfizer Limited (PFIZER.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5015.65.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.58 and a market capitalization of 235.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.